Non-Invasive Prenatal Screening or NIPT is a non-invasive screening method used to determine the chromosomal abnormalities of the fetus using maternal blood when the gestational age reaches 10-20 weeks.
With Whole-Genome Next Generation Sequencing (NGS) technology, the results are highly reliable, precise and accurate with no associated risks for the mother and the fetus.
Terms and Conditions:
Share